mtDNA drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (15)
Papers in which this entity is mentioned.
- Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. (2026)
- Parent-of-origin effects on complex traits in up to 236,781 individuals. (2025)
- ESPRESSO: Robust discovery and quantification of transcript isoforms from error-prone long-read RNA-seq data. (2023)
- The complete sequence of a human genome. (2022)
- Cell-free DNA technologies for the analysis of brain cancer. (2022)
- SVXplorer: Three-tier approach to identification of structural variants via sequential recombination of discordant cluster signatures. (2020)
- Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
- Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. (2018)
- A SNP panel for identification of DNA and RNA specimens. (2018)
- Enhanced detection of circulating tumor DNA by fragment size analysis. (2018)
- Patterns and mechanisms of structural variations in human cancer. (2018)
- The human gene damage index as a gene-level approach to prioritizing exome variants. (2015)
- DNA copy number, including telomeres and mitochondria, assayed using next-generation sequencing. (2010)
- Are we training pit bulls to review our manuscripts? (2009)
- RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. (2008)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| mitochondrial dna | drug | 17 | 19 |
| mtdna | drug | 10 | 24 |
| mitochondrial genome | drug | 4 | 5 |
| human mtdna | drug | 1 | 1 |